Rik Vandevenne

Rik joined River Cities in 2004 to focus on information technology and healthcare investment opportunities. He brings to River Cities a strong background in strategy and business management at high-growth companies. Rik is responsible for sourcing and evaluating new investment opportunities and working with executives in portfolio companies on marketing, sales execution, product development and strategy. Prior to his private equity career, Rik gained experience working with venture backed companies in the strategy group of Scient, a global eBusiness consulting firm. Before Scient, Rik worked for four years at Accenture, first in the healthcare services group and then at the Internet Center of Excellence where he helped launch several venture-backed companies as well as worked on the team that developed the online music platform for BestBuy. Rik serves on the boards of Netsertive, APS, Continuity and Univa and is an observer at Veran Medical. Rik was previously an observer on the board of Pioneer Surgical, sold to RTI Surgical (Nasdaq: RTIX) in 2013 and was on the board of EndoChoice (NYSE: GI) which sold to Boston Scientific for $210MM in 2016. He was previously on the board of Fullscope (sold to Edgewater (Nasdaq: EDGW) in 2009). Rik graduated from Vanderbilt University where he received his BE in Mechanical Engineering, and he received an MBA from Duke University. Rik was until recently the chairman of the Governance Group for the Center for Entrepreneurial Development (CED), one of the largest entrepreneurial organizations in the country, and is a frequent guest lecturer at Duke University on Entrepreneurship and Venture Capital. Rik is also a member of the Board of Directors of the Southeastern Medical Device Association (SEMDA), which supports and promotes medical device companies in the Southeast.